S&P 500   3,750.77 (-2.57%)
DOW   30,303.17 (-2.05%)
QQQ   317.46 (-3.39%)
AAPL   140.92 (-1.56%)
MSFT   232.30 (-0.01%)
FB   270.90 (-3.95%)
GOOGL   1,810.00 (-5.13%)
AMZN   3,210.00 (-3.49%)
TSLA   829.00 (-6.13%)
NVDA   515.20 (-4.13%)
BABA   258.20 (-2.90%)
CGC   37.82 (+6.48%)
GE   11.35 (+0.53%)
MU   75.08 (-5.57%)
AMD   88.66 (-6.39%)
NIO   56.36 (-6.55%)
T   29.03 (-2.42%)
F   10.75 (-3.93%)
ACB   11.10 (+4.03%)
BA   193.00 (-4.48%)
DIS   162.98 (-3.88%)
NFLX   522.95 (-6.94%)
GILD   65.18 (-2.28%)
S&P 500   3,750.77 (-2.57%)
DOW   30,303.17 (-2.05%)
QQQ   317.46 (-3.39%)
AAPL   140.92 (-1.56%)
MSFT   232.30 (-0.01%)
FB   270.90 (-3.95%)
GOOGL   1,810.00 (-5.13%)
AMZN   3,210.00 (-3.49%)
TSLA   829.00 (-6.13%)
NVDA   515.20 (-4.13%)
BABA   258.20 (-2.90%)
CGC   37.82 (+6.48%)
GE   11.35 (+0.53%)
MU   75.08 (-5.57%)
AMD   88.66 (-6.39%)
NIO   56.36 (-6.55%)
T   29.03 (-2.42%)
F   10.75 (-3.93%)
ACB   11.10 (+4.03%)
BA   193.00 (-4.48%)
DIS   162.98 (-3.88%)
NFLX   522.95 (-6.94%)
GILD   65.18 (-2.28%)
S&P 500   3,750.77 (-2.57%)
DOW   30,303.17 (-2.05%)
QQQ   317.46 (-3.39%)
AAPL   140.92 (-1.56%)
MSFT   232.30 (-0.01%)
FB   270.90 (-3.95%)
GOOGL   1,810.00 (-5.13%)
AMZN   3,210.00 (-3.49%)
TSLA   829.00 (-6.13%)
NVDA   515.20 (-4.13%)
BABA   258.20 (-2.90%)
CGC   37.82 (+6.48%)
GE   11.35 (+0.53%)
MU   75.08 (-5.57%)
AMD   88.66 (-6.39%)
NIO   56.36 (-6.55%)
T   29.03 (-2.42%)
F   10.75 (-3.93%)
ACB   11.10 (+4.03%)
BA   193.00 (-4.48%)
DIS   162.98 (-3.88%)
NFLX   522.95 (-6.94%)
GILD   65.18 (-2.28%)
S&P 500   3,750.77 (-2.57%)
DOW   30,303.17 (-2.05%)
QQQ   317.46 (-3.39%)
AAPL   140.92 (-1.56%)
MSFT   232.30 (-0.01%)
FB   270.90 (-3.95%)
GOOGL   1,810.00 (-5.13%)
AMZN   3,210.00 (-3.49%)
TSLA   829.00 (-6.13%)
NVDA   515.20 (-4.13%)
BABA   258.20 (-2.90%)
CGC   37.82 (+6.48%)
GE   11.35 (+0.53%)
MU   75.08 (-5.57%)
AMD   88.66 (-6.39%)
NIO   56.36 (-6.55%)
T   29.03 (-2.42%)
F   10.75 (-3.93%)
ACB   11.10 (+4.03%)
BA   193.00 (-4.48%)
DIS   162.98 (-3.88%)
NFLX   522.95 (-6.94%)
GILD   65.18 (-2.28%)
Log in
CVE:GSD

Devonian Health Group Inc. (GSD.V) Stock Forecast, Price & News

C$0.22
-0.01 (-2.22 %)
(As of 01/27/2021 03:45 PM ET)
Add
Compare
Today's Range
C$0.22
Now: C$0.22▼
C$0.24
50-Day Range
C$0.00
MA: C$0.16▼
C$0.28
52-Week Range
C$0.09
Now: C$0.22▼
C$0.35
Volume9,625 shs
Average Volume49,620 shs
Market CapitalizationC$20.48 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, a Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric or duodenal ulcers; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, it acquires drug and health product licenses, as well as distributes pharmaceutical products. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2015 and is headquartered in Québec, Canada.

MarketRank™

Overall MarketRank™

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange CVE
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolCVE:GSD
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.groupedevonian.com
Phone450-937-6696
EmployeesN/A
Year FoundedN/A

Debt

Debt-to-Equity Ratio55.07
Current Ratio0.41
Quick Ratio0.36

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesC$1.65 million
Price / Sales12.44
Cash FlowC$0.00 per share
Price / Cash Flow56.25
Book ValueC$0.10 per share
Price / Book2.12

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares93,110,000
Market CapC$20.48 million
Next Earnings DateN/A
OptionableNot Optionable
C$0.22
-0.01 (-2.22 %)
(As of 01/27/2021 03:45 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GSD News and Ratings via Email

Sign-up to receive the latest news and ratings for GSD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Devonian Health Group Inc. (GSD.V) (CVE:GSD) Frequently Asked Questions

How has Devonian Health Group Inc. (GSD.V)'s stock been impacted by COVID-19?

Devonian Health Group Inc. (GSD.V)'s stock was trading at C$0.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, GSD shares have increased by 0.0% and is now trading at C$0.22.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Devonian Health Group Inc. (GSD.V)?

Wall Street analysts have given Devonian Health Group Inc. (GSD.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Devonian Health Group Inc. (GSD.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Devonian Health Group Inc. (GSD.V)'s key competitors?

Some companies that are related to Devonian Health Group Inc. (GSD.V) include OptiBiotix Health Plc (OPTI.L) (OPTI), Microbix Biosystems Inc. (MBX.TO) (MBX), Hvivo (HVO), IXICO plc (IXI.L) (IXI), Tissue Regenix Group plc (TRX.L) (TRX), Covalon Technologies Ltd. (COV.V) (COV), Hemogenyx Pharmaceuticals Plc (HEMO.L) (HEMO), Rua Life Sciences Plc (RUA.L) (RUA), Emerald Health Therapeutics, Inc. (EMH.V) (EMH), ProMIS Neurosciences, Inc. (PMN.TO) (PMN), Fusion Antibodies plc (FAB.L) (FAB), IntelGenx Technologies Corp. (IGX.V) (IGX), ImmuPharma plc (IMM.L) (IMM), Collagen Solutions plc (COS.L) (COS) and Nuvo Pharmaceuticals Inc. (NRI.TO) (NRI).
View all of GSD's competitors.

Who are Devonian Health Group Inc. (GSD.V)'s key executives?

Devonian Health Group Inc. (GSD.V)'s management team includes the following people:
  • Dr. Andre P. Boulet, Chairman, Pres, CEO & Sec. (Age 61, Pay $212.4k)
  • Ms. Colette Laurin, Interim CFO & Corp. Controller
  • Mr. Tarique Sayed, Sec. & Independent Director

What is Devonian Health Group Inc. (GSD.V)'s stock symbol?

Devonian Health Group Inc. (GSD.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "GSD."

How do I buy shares of Devonian Health Group Inc. (GSD.V)?

Shares of GSD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Devonian Health Group Inc. (GSD.V)'s stock price today?

One share of GSD stock can currently be purchased for approximately C$0.22.

How big of a company is Devonian Health Group Inc. (GSD.V)?

Devonian Health Group Inc. (GSD.V) has a market capitalization of C$20.48 million and generates C$1.65 million in revenue each year.

What is Devonian Health Group Inc. (GSD.V)'s official website?

The official website for Devonian Health Group Inc. (GSD.V) is www.groupedevonian.com.

How can I contact Devonian Health Group Inc. (GSD.V)?

The company can be reached via phone at 450-937-6696.

This page was last updated on 1/27/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.